Mirae Asset Global Investments
AAPG

Mirae Asset Global Investments’s Ascentage Pharma AAPG Stock Holding History

Mirae Asset Global Investments’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,546
Closed -$66.8K – 1757
2025
Q4 		$66.8K Buy
2,546
+83
+3% +$2.72K ﹤0.01% 1339
2025
Q3 		$96.2K Buy
+2,463
New +$99.7K ﹤0.01% 1221

Other funds holding AAPG

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Mirae Asset Global Investments's AAPG Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of Ascentage Pharma (AAPG) in Q1 2026, closing a stake of 2,546 shares — an estimated $66.8K sold.

Mirae Asset Global Investments first reported a position in AAPG in Q3 2025 and held it in 2 quarters. The position peaked at $96.2K in Q3 2025. 7 funds tracked by Wall St. Rank hold AAPG as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining Ascentage Pharma position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,546 Ascentage Pharma shares in Q1 2026, an estimated $66.8K.
  • Mirae Asset Global Investments first reported a position in Ascentage Pharma in Q3 2025 and held it in 2 quarters.
  • Mirae Asset Global Investments's Ascentage Pharma position peaked at $96.2K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Ascentage Pharma as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.